Investors

Abattis Bioceuticals is a public company traded on the CSE in Canada and through the OTCQB market in the United States.

Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. is a specialty life sciences and biotechnology company. Through its operations and wholly owned subsidiaries, the Company has a broad range of capabilities including cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.

Subsidiaries:

Northern Vine Laboratories Inc.

Vergence Naturals

Data


Exchanges
CSE (Canada): ATT
OCTQB (United States): ATTBF
Latest Report: Aug. 29, 2017 Interim Financials
CIK: 0001515768
Fiscal Year End: 9/30
SIC - Industry Class: 2833 - medicinal and botanicals
Incorporated In: British Columbia, Canada
Year of Inc.: 1997






    • PRESENTATIONS
    • NEWS & FILINGS
    • STRUCTURE
    Investor Overview 2017


Officers

Robert Abenante – President & CEO

Anthony Jackson – CFO

Rene David – COO

Dr. Shuang Xie – CTO
Christina Boddy – Corporate Secretary

Directors

Robert Abenante – Director

Rene David – Director

Dr. William Panenka – Director

Peter Gordon – Director

Jim Irving – Director
Dr. Shaung Xie –Director


Auditors/Accounting

Dale Matheson Carr-Hilton Labonte
1140 West Pender St., Suite 1500 Vancouver, BC,
V6E 4G1 Canada

Securities Counsel

Clark Wilson, Vancouver, Canada

Transfer Agent

Computershare Transfer Company of Canada Inc.